Despite the significance of proliferation of residual breast cancer cells, most prognostic factors measure demographic characteristics of the patient (e.g. age), tumor status (e.g. grade, size, spread) or histological features (e.g. hormone receptor status, HER-2 status, and nodal status). Here, ERBB2 is linked to breast cancer.